Recherche avancée
Instruments
Nom | Mnemo | Place boursière | Volume moyen | Cours | Type | |
---|---|---|---|---|---|---|
LOCKHEED MARTIN CORPORATION | LMT | Buenos Aires S.E. +1 Autres | 1 017 | 25 675 ARS | Action | |
LOCKHEED MARTIN CORPORATION | LMTD | Buenos Aires S.E. | 158 | 25,6 USD | ||
LOCKHEED MARTIN CORPORATION | LMTB34 | Sao Paulo | 32 | 2 380 BRL | Action | |
LOCKHEED MARTIN CORPORATION | LMT | Nyse +11 Autres | 784 659 | 466,2 USD | Action | |
LOCKHEED MARTIN CORPORATION | LOM | Deutsche Boerse AG | 83 | 427,4 EUR | ||
LOCKHEED MARTIN CORPORATION | LOM | Xetra | 561 | 426,8 EUR | ||
LOCKHEED MARTIN CORPORATION | LMT * | Mexican S.E. | 301 | 7 700 MXN | ||
LOCKHEED MARTIN CORPORATION | LMT | Swiss Exchange | - | 430 CHF | ||
LOCKHEED MARTIN CORPORATION | 0R3E | London S.E. | 131 | 469,9 USD | ||
LOCKHEED MARTIN CORPORATION | LMT | Wiener Boerse | 9 | 426,9 EUR | ||
LOCKHEED MARTIN CORPORATION | LOM | Börse Stuttgart | 25 | 428,2 EUR | ||
LOCKHEED MARTIN CORPORATION | LOM | BOERSE MUENCHEN | 199 | 428 EUR | ||
LOCKHEED MARTIN CORPORATION | 4LMT | Borsa Italiana | - | 428,8 EUR | ||
LOCKHEED MARTIN CORPORATION | LMT | Berne S.E. | 3 | 414 CHF | ||
LOCKHEED MARTIN CORPORATION | LOM | Bulgaria S.E. | 1 | 439,1 EUR | ||
MARTIN MARIETTA MATERIALS, INC. | MLM | Nyse +6 Autres | 451 843 | 580,8 USD | Action | |
MARTIN MARIETTA MATERIALS, INC. | MMX | Deutsche Boerse AG | - | 534,4 EUR | ||
MARTIN MARIETTA MATERIALS, INC. | MLM * | Mexican S.E. | 16 | 10 105 MXN | ||
MARTIN MARIETTA MATERIALS, INC. | MMX | Börse Stuttgart | - | 533,2 EUR | ||
MARTIN MARIETTA MATERIALS, INC. | 0JZ0 | London S.E. | 55 | 584,8 USD | ||
MARTIN MARIETTA MATERIALS, INC. | MMX | BOERSE MUENCHEN | - | 533,2 EUR | ||
MARTIN MARIETTA MATERIALS, INC. | MMX | Berne S.E. | - | - CHF | ||
MAINSTAY MACKAY DEFINEDTERM MUNICIPAL OPPORTUNITIES FUND | MMD | Nyse | 57 946 | 16,5 USD | Action | |
USHA MARTIN LIMITED | USHAMART | Bombay S.E. +1 Autres | 91 753 | 357,8 INR | Action | |
USHA MARTIN LIMITED | USHAMART | NSE India S.E. | 1 675 002 | 357,8 INR | ||
MARTIN BURN LIMITED | MARBU6 | Bombay S.E. | 1 525 | 50,82 INR | Action | |
USHA MARTIN LIMITED | USHMA | LUXEMBOURG S.E. | - | 21,2 USD | Action | |
MARTIN MIDSTREAM PARTNERS L.P. | MMLP | Nasdaq | 66 919 | 3,02 USD | Action | |
MARTIN CURRIE GLOBAL PORTFOLIO TRUST PLC | MNP | London S.E. | 94 453 | 378 GBX | Action |
Actualités (26)
Profils Sociétés (87)
Lockheed Martin Corporation est spécialisé dans la conception, la fabrication et la commercialisation de systèmes aéronautiques, sous-marins et spatiaux. Le CA par activité se répartit comme suit : - vente de systèmes aéronautiques (40,7%) : avions milit ...
Lockheed Martin Corporation est spécialisé dans la conception, la fabrication et la commercialisation de systèmes aéronautiques, sous-marins et spatiaux. Le CA par activité se répartit comme suit : - vente de systèmes aéronautiques (40,7%) : avions milit ...
Lockheed Martin Corporation est spécialisé dans la conception, la fabrication et la commercialisation de systèmes aéronautiques, sous-marins et spatiaux. Le CA par activité se répartit comme suit : - vente de systèmes aéronautiques (40,7%) : avions milit ...
Jerónimo Martins, SGPS, S.A. est un groupe qui détient des actifs dans le domaine de l'alimentation, principalement dans la distribution, avec des positions de leader en Pologne et au Portugal. En 2023, le groupe a enregistré un chiffre d'affaires de 30,6 ...
Martin Marietta Materials, Inc. est le 2e producteur américain de granulats et de matériaux de construction. Le CA par famille de produits se répartit comme suit : - granulats et matériaux de construction (94,5%) : granulats (58,7% du CA), bétons prêts à ...
Jerónimo Martins, SGPS, S.A. est un groupe qui détient des actifs dans le domaine de l'alimentation, principalement dans la distribution, avec des positions de leader en Pologne et au Portugal. En 2023, le groupe a enregistré un chiffre d'affaires de 30,6 ...
United Spirits Limited est le premier producteur de spiritueux en Inde. Le groupe propose du scotch (marques Black Dog, Dalmore, Jura et White & Mackay), du Whisky (Antiquity, Bagpiper, McDowell's No.1 et McDowell's No.1 Platinum), du brandy (McDowell's V ...
Agrimin Limited est une société de développement d'engrais basée en Australie. L'activité principale de la société consiste à faire progresser le projet de potasse Mackay en Australie occidentale. Elle opère dans le domaine de l'exploration et du développ ...
Rémy Cointreau figure parmi les principaux producteurs et distributeurs mondiaux de cognacs, de spiritueux et de liqueurs. Le CA par famille de produits se répartit comme suit : - cognacs (71%) : marque Rémy Martin et LOUIS XIII ; - liqueurs et spiritue ...
Rémy Cointreau figure parmi les principaux producteurs et distributeurs mondiaux de cognacs, de spiritueux et de liqueurs. Le CA par famille de produits se répartit comme suit : - cognacs (71%) : marque Rémy Martin et LOUIS XIII ; - liqueurs et spiritue ...
Insiders
Martin Mackay was associated with Newcastle Agri Terminal Pty Ltd.
as an Executive Director.
He is also the founder of the company, which was founded in 2014.
Martin W.
MacKay is the founder and currently holds the position of Chairman & Chief Executive Officer at Rallybio LLC, which was founded in 2018.
He is also the Executive Chairman at Rallybio Corp., founded in 2018.
In addition to his founding positions, Dr. MacKay currently serves as the Chief Executive Officer at Calyx Group Ltd.
(Ireland) and Rallybio Holdings LLC.
He is also a Director at Charles River Laboratories International, Inc., an Independent Director at Charles River Laboratories, Inc., and an Independent Director at Novo Nordisk A since 2018.
Dr. MacKay has held former positions as the Chief Executive Officer at Vecta Software Corp.
Ltd., Neverfail, Inc., and Neverfail Ltd.
He was also a Director at Encysive Pharmaceuticals, Inc. in 2008.
Additionally, he has served as the Operations Director at The Dun & Bradstreet Corp.
and Director-Business Development at NorthgateArinso, Inc. Dr. MacKay was an Independent Director at 5:01 Acquisition Corp.
from 2020 to 2022.
He held the position of Senior Vice President-Worldwide Development at Pfizer Inc. from 1995 to 2009 and President-Research & Development at AstraZeneca PLC from 2010 to 2013.
From 2013 to 2017, he was the Global Head-Research & Development at Alexion Pharmaceuticals, Inc. Dr. MacKay has also held positions at VeriSign, Inc., BASF Performance Products Ltd.
(United Kingdom), New Leaf Venture Partners LLC, Pfizer (St. Louis), CRI Worldwide LLC, PeopleSoft USA, Inc., Accenture LLC, Ciba-Geigy Pharmaceuticals, and Beecham Pharmaceuticals (UK).
Dr. MacKay obtained a doctorate degree from The University of Edinburgh in 1984 and an undergraduate degree from Heriot-Watt University in 1979.
James Morrison MacKay is currently the Chairman of True Product ID Technology (Beijing) Ltd.
He was previously the Chairman of MacKay Life Sciences, Inc. and Sure Trace Security Corp.
In 2007, he was the Chairman of True Product ID, Inc. and in 2006, he was the Interim Chairman of True Product ID, Inc.
Geoff MacKay was the founder of Avrobio, Inc. (founded in 2015) where he held the title of President, Chief Executive Officer & Director until 2023.
He is also the founder of eGenesis, Inc. (founded in 2015) where he held the title of Chief Executive Officer & Director until 2017.
Currently, Mr. MacKay is the Chairman of Satellos Bioscience, Inc. since 2018 and a Director at RedactBio, Inc. His former positions include President & Chief Executive Officer at Organogenesis, Inc. from 2003 to 2014, Chief Executive Officer at Organogenesis, Inc., Chairman of Massachusetts Biotechnology Council, Chairman of Alliance for Regenerative Medicine, Chairman of Satellos Bioscience, Inc., Independent Director at RepliCel Life Sciences, Inc., Director at Centre For Commercialization of Regenerative Medicine, Independent Director at Talaris Therapeutics, Inc., Director at Gemstone Biotherapeutics LLC, and Vice President at Novartis AG.
Mr. MacKay also served as an Advisor at Atlas Venture Advisors, Inc. from 2015 to 2023.
He obtained his undergraduate degree from McGill University.
Aucun résultat pour cette recherche
- Bourse
- Recherche avancée
- Martin MacKay